Registration is complimentary for regulatory professionals at biopharma companies.
Register for Veeva Summit

You’re invited to specialized sessions curated by regulatory experts from pharma and biotech companies.

We’re hosting Veeva R&D and Quality Summit as an online experience on October 14 to connect the industry while prioritizing the safety of our community.

Below, you’ll find a taste of Summit with highlights from the regulatory track.

Learn more

Featured Regulatory Sessions

As an attendee, you will have access to dedicated regulatory sessions, including interactive Q&A with industry experts. Featured customer-led sessions include:


Roche’s regulatory transformation lead will share how his team is spearheading efforts to bring different regulatory functions together under a common set of modern business capabilities. Learn more about their OneRegulatory strategies and roadmap to meet both present and future patient needs.

Vijay Reddi Roche
Regulatory Transformational Lead
Marc Gabriel Veeva
Senior Director, Vault RIM

Dermavant is one of the first biopharmas to publish a major NDA using Vault RIM. Join this session to hear how they managed that process using Vault Submissions Publishing and hired new strategic resources to support their growing portfolio.

Jason Maze Dermavant Sciences
Director, Global Regulatory Systems and Information Mgmt.
Dan Gray Dermavant Sciences
Regulatory Systems Analyst

Moderna worked with multiple health authorities and partners during their rapid roll-out of the COVID-19 vaccine. Learn how they shifted their health authority question management from reactive to proactive and aligned global efforts around a common goal.

Jennifer LaFleur Moderna
Sr. Director, Global Regulatory Science Operations
Maulik Mahant Moderna
Sr. Systems Engineer, Regulatory and Clinical Digital Applications and Platforms

Hear how Eli Lilly leveraged an agile methodology to decrease the time it takes to deploy Vault RIM capabilities. They’ll review how they pivoted from a traditional waterfall methodology, what worked well, and their top takeaways for others tackling a similar challenge.

Paula Hudson Eli Lilly and Company
Advisor, Global Regulatory Affairs
Amber Karns Eli Lilly and Company
Director, Information & Digital Solutions, Global Regulatory Affairs

One day to learn from the best in life sciences